• Digoxin as a Na+/K+ ATPase Pump Inhibitor in Translational R

  2026-06-02

  Digoxin stands out for its dual use: as a benchmark tool in cardiac contractility modulation and as an emerging antiviral in chikungunya research. This article deciphers experimental protocols, troubleshooting, and comparative advantages, empowering scientists to leverage Digoxin’s validated selectivity and high purity from APExBIO for robust, cross-domain investigations.

• HCN Channels Mediate Cardiac Heat Response via a Conserved M

  2026-06-02

  Wu et al. (2023) reveal that a specific motif in HCN4 channels is essential for cardiac pacemaker cells to sense temperature and regulate heart rate in response to heat. This study clarifies the molecular mechanism behind heat-induced heart rate acceleration and broadens our understanding of HCN channel function in membrane excitability.

• Trichostatin A (TSA): Applied Epigenetic Modulation in Cance

  2026-06-01

  Trichostatin A (TSA) is a gold-standard HDAC inhibitor, offering robust control over histone acetylation for studies targeting epigenetic regulation in cancer. This article delivers actionable protocols, troubleshooting strategies, and workflow enhancements—empowering researchers to harness TSA for high-precision oncology and cell differentiation assays.

• CLK2 Inhibition Targets Platinum Resistance in Ovarian Cance

  2026-06-01

  The reference study reveals that Cdc2-like kinase 2 (CLK2) drives platinum resistance in ovarian cancer by enhancing DNA repair through BRCA1 phosphorylation. Targeting CLK2 represents a promising strategy to overcome chemotherapy resistance, providing a mechanistic basis for alternative splicing modulation and new drug development.

• (R,S)-Anatabine: Unraveling Dual Pathways in Neurodegenerati

  2026-05-31

  (R,S)-Anatabine is a potent tool for investigating amyloid-beta and inflammation in Alzheimer's disease models. This article delves into its mechanistic depth, translational relevance, and protocol best practices, offering a uniquely integrative perspective for neurodegeneration research.

• NEIL1 Promotes Colorectal Cancer via COL17A1 Transcriptional

  2026-05-30

  Cao et al. reveal that NEIL1, a base excision repair enzyme, directly regulates COL17A1 transcription to drive colorectal cancer (CRC) initiation and establish an immunosuppressive tumor microenvironment. This mechanistic insight highlights NEIL1 as a promising therapeutic target and redefines the role of DNA repair factors in early CRC pathogenesis.

• GSK3 Inhibition as a Host-Directed Strategy Against Tubercul

  2026-05-29

  The referenced iScience study demonstrates that inhibition of glycogen synthase kinase 3 (GSK3) in human macrophages effectively restricts intracellular Mycobacterium tuberculosis growth. This work advances host-directed therapy (HDT) concepts by showing that modulation of host kinases, rather than direct antibacterial action, can enhance innate immune antimicrobial capacity, suggesting new adjunctive strategies for multi-drug resistant tuberculosis treatment.

• Cell Surface GlycoRNA-RBP Clusters Enable Peptide Entry: Ins

  2026-05-29

  The reference study reveals RNA binding proteins (RBPs) as previously unrecognized components of the cell surface, forming nanoclusters with glycoRNAs that facilitate cell-penetrating peptide (CPP) entry. This discovery reshapes our understanding of surface proteomics and suggests new routes for mapping extracellular interactomes.

• Mechanomemory, F-Actin, and YAP Translocation After Intermit

  2026-05-28

  This study demonstrates that short, intermittent mechanical stresses induce lasting mechanomemory in cells, characterized by enhanced nuclear translocation of YAP via F-actin accumulation. The findings clarify the cytoskeletal basis for force-dependent gene regulation and highlight the specificity of actomyosin involvement, informing future research on cellular mechanotransduction.

• LDH Cytotoxicity Assay Kit: Precision Cell Cytotoxicity Meas

  2026-05-28

  The LDH Cytotoxicity Assay Kit from APExBIO delivers sensitive, non-radioactive cell cytotoxicity measurement ideal for validating nanomaterial biocompatibility and apoptosis detection in advanced biomedical research. This guide explores experimental workflows, troubleshooting, and key innovations that set this kit apart for applications in cancer research and magnetic nanocomposite evaluation.

• DOT1L Inhibition Enhances Lenalidomide Response in Myeloma

  2026-05-27

  The referenced study demonstrates that inhibiting DOT1L, a key epigenetic regulator, reprograms innate immune signaling and potentiates the anti-myeloma effects of immunomodulatory drugs such as Lenalidomide. These findings offer a mechanistic rationale for combining DOT1L inhibitors with established immune system activation agents, potentially advancing therapeutic strategies in multiple myeloma.

• Fosinopril Sodium: Dual Elimination ACE Inhibitor in Hyperte

  2026-05-27

  The reference study systematically characterizes fosinopril sodium, a phosphinic acid ACE inhibitor, highlighting its unique pharmacokinetic profile—namely, dual renal and hepatic elimination. This pharmacological innovation enables more reliable blood pressure modulation across diverse patient models, including those with renal impairment, advancing hypertension and cardiovascular disease research.

• Pam3CSK4 as a TLR1/2 Agonist: Applied Immune Activation Work

  2026-05-26

  Pam3CSK4 unlocks precise TLR1/2 pathway activation, enabling reproducible dissection of innate immune mechanisms and inflammation models. This article delivers actionable workflows, troubleshooting, and data-driven insights—bridging advanced immunology with neuro-immune research through APExBIO's trusted standard.

• Panoramic Opto-Electrical Mapping Advances Mouse Cardiac Res

  2026-05-26

  The referenced study introduces a panoramic opto-electrical measurement and stimulation (POEMS) system, enabling simultaneous high-resolution optical and electrical mapping of mouse hearts. This technical advance facilitates comprehensive, customizable investigations of cardiac electrophysiology and optogenetic interventions, paving the way for deeper mechanistic insights and improved translational models.

• Applied Workflows with MK-1775 Wee1 Kinase Inhibitor in Canc

  2026-05-25

  MK-1775 is transforming preclinical cancer workflows by enabling precise cell cycle checkpoint abrogation and sensitization of p53-deficient tumor cells. This guide details actionable in vitro protocols, troubleshooting strategies, and leverages leading-edge insights from recent methodology advances.

16108 records 1/1074 page Next 12345 下5页 Last page